Votre sélection est vide.
Sélectionnez des ETF pour les comparer les uns aux autres.
Ajoutez un ETF à la sélection en le sélectionnant dans le sélecteur d’ETF ou sous « Comparer » sous le profil de l’ETF.
Edwards Lifesciences Corp.
ISIN US28176E1082
|Code du titre 936853
Cap. boursière (en EUR)
42,735 m
Country
United States
Secteur
Healthcare
Rendement en dividendes
0.00%
Overview
Description
Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.
Healthcare Healthcare Equipment General Medical Devices United States
Financials
Key metrics
| Market capitalisation, EUR | 42,735 m |
| EPS, EUR | 1.60 |
| P/B ratio | 4.7 |
| P/E ratio | 46.4 |
| Dividend yield | 0.00% |
Compte de résultat (2025)
| Revenue, EUR | 5,378 m |
| Net income, EUR | 940 m |
| Profit margin | 17.47% |
Quel ETF contient Edwards Lifesciences Corp. ?
Il y a 61 ETF qui contiennent Edwards Lifesciences Corp.. Tous ces ETF sont énumérés dans le tableau ci-dessous. L’ETF ayant la plus grande pondération de Edwards Lifesciences Corp. est le Amundi MSCI Disruptive Technology UCITS ETF Acc.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.